Patient Positioning Systems Market
The global patient positioning systems market in terms of revenue was estimated to be worth $1.4 billion in 2022 and is poised to reach $1.7 billion by 2030, growing at a CAGR of 4.0% from 2023 to 2030. Growing demand for minimally invasive procedures, as well as increasing funding for the construction of new healthcare facilities, are driving market expansion. Furthermore, because of advances in early sickness identification, infrastructure development, and the rising presence of multinational corporations, developing countries are expected to provide appealing opportunities for market participants during the next five years.
Patient Positioning System: Market Dynamics
Driver: Rising government funds for hospital expansions
The rise in chronic diseases and the growing preference for minimally invasive procedures is driving the growth of hospitals offering treatments with specialized staff and equipment. To meet patient demand, hospitals are investing in innovative technologies and expanding operating rooms.
For example, in May 2022, the University of Colorado Anschutz Medical Campus announced a $200 million investment over the next five years to create the Gates Institute. The Gates Institute will be a research and treatment center that focuses on the development of new regenerative, cellular, and gene therapies for a variety of serious illnesses.
In October 2021, the Scottish Government invested €300 million in the winter funding package to increase the capacity of NHS hospitals and primary care centers. The funding will be used to expand operating rooms, hire more staff, and purchase new equipment.
These investments are a sign of the growing importance of hospitals in providing high-quality care for patients with chronic diseases. As the population ages and the prevalence of chronic diseases increases, hospitals will need to continue to invest in innovative technologies and expand operating rooms to meet the needs of patients.
Here are some additional details about the two examples I mentioned:
- The Gates Institute at the University of Colorado Anschutz Medical Campus will focus on the development of new regenerative, cellular, and gene therapies for a variety of serious illnesses. These therapies have the potential to revolutionize the way we treat diseases, and the Gates Institute will be at the forefront of this research.
- The Scottish Government's winter funding package will be used to expand operating rooms, hire more staff, and purchase new equipment at NHS hospitals and primary care centers. This investment will help to ensure that patients in Scotland have access to high-quality care, even during the winter months when demand for hospital services is highest.
Restraint: Implementation of excise duty on taxable medical devices
The Patient Protection and Affordable Care Act imposed a 2.3% excise tax on domestic sales of Class I, II, and III medical equipment. This tax is charged on medical devices manufactured or imported into the United States. This adoption will have an influence on the market for patient positioning systems, which are classified as Class I and II medical devices in the United States. The levy will also reduce manufacturers' profit margins, raising the price of medical items in the nation. This, in turn, may cause a delay in the procurement of new instruments, affecting market growth to some extent.
Because the United States is a big market for patient positioning systems, the country's implementation of a medical products excise tax is expected to have a global impact on the sector.
Opportunities: Emerging markets
Emerging markets such as India, China, and Brazil are likely to provide market participants with substantial growth possibilities in the next years. The enormous population, particularly in India and China, provides a long-term market for patient positioning systems. In these locations, lifestyle changes and poor food habits have increased the prevalence of chronic illnesses such as cancer and CVDs. According to GLOBOCAN, for example, China accounted for 24% of newly diagnosed cases and 30% of cancer-related fatalities globally; this figure is anticipated to rise by 2030. Similarly, cancer incidence in India has increased from 1.1 million in 2018 to 1.3 million in 2020.
Given these nations' substantial development potential, global businesses are focused on strategic innovations including distribution partnerships with local enterprises to boost their market position.
Challenges: Availability of refurbished patient positioning systems
The availability of refurbished patient positioning systems is seen as a challenge for the growth of the market. DRE Medical, Inc. (USA), Future Health Concepts (USA) and Soma Technology, Inc. (USA) are some of the companies offering refurbished patient positioning systems in the market. Many end users are currently switching to refurbished systems due to declining healthcare spending in major global healthcare markets. Additionally, end users prefer to operate cost-effective systems in developing countries, which are considered price-sensitive markets. Given these factors, the demand for refurbished patient positioning systems is expected to increase in the coming years, as these systems offer the same functionality as new equipment at a lower cost. This, in turn, is expected to hamper the revenue of companies offering branded patient positioning systems in the market.
Patient positioning systems Market Ecosystem:
By product type, the tables segment accounted for the largest share during the forecast period.
The market for patient positioning systems is segmented into tables, accessories, and others. The tables segment dominates the patient positioning systems market. As the need for technologically improved operating tables rises as a result of minimally invasive surgery, greater innovation in this industry is expected to provide significant growth opportunities for market players.
By application type, the cancer therapy segment is expected to witness the highest growth during the forecast period.
The patient positioning systems market is divided into three applications: cancer therapy, surgery, and illness diagnostics. During the projected period, the cancer therapy sector is predicted to increase the most. Cancer treatments, such as radiation therapy or proton therapy/precision therapy, target the area of the body where tumours are located. In cancer therapy, using patient positioning systems decreases discomfort and problems while also ensuring improved results. As a result, rising awareness of proton therapy and other cancer therapy sectors is likely to fuel market expansion in this application area.
By End User, Ambulatory Surgical Centers segment to grow at the fastest rate during the forecast period.
The worldwide patient positioning systems market is divided into hospitals and clinics, Ambulatory Surgical Centres, diagnostic labs, and other end users based on end user. ASCs greatly contribute to improving care quality while lowering treatment costs. As a consequence of these benefits, a greater number of patients are choosing to have operations performed at ASCs, boosting the segment's development.
North America is expected to be the largest market during the forecast period.
North America held the largest patient positioning systems market share in 2021. Its large share can be attributed to the increasing number of surgical procedures, growing investments by hospitals to modernize operating rooms, and the increasing patient population. Additionally, the growth of the geriatric population and the increasing prevalence of lifestyle diseases such as arthritis and obesity in this region are key factors in the growth of the patient positioning system. As the increase in the number of these diseases requires hospitalization of patients and depends on the positioning system of the patient, it contributes to its growth.
Key Market Players
As of 2021, prominent players in the patient positioning systems market are Stryker Corporation (US), Steris Plc. (US), Hill-Rom, Inc. (US), Getinge AB (Germany), C-RAD (Sweden), Smith & Nephew plc (UK), Guangzhou Renfu Medical Equipment CO, LTD (China), Medline Industries, LP. (US), Elekta AB (Sweden), Span America Medical Systems, Inc. (US), LEONI AG (Germany), Medtronic PLC (US), ORFIT INDUSTRIES N.V. (Belgium), Famed Zywiec Sp. z o. o (Poland), and Oncotech (Turkey) among others.
Scope of the Report:
This report has segmented the global Patient positioning systems market based on product, application, end-user, and region.
Global Patient Positioning System Market, by product
- Tables
- Surgical Table
- Radiolucent Imaging Table
- Examination Table
- Accessories
- Radiotherapy Immobilization/ Fixation Products
- Other Accessories
- Other Patient Positioning System
Global Patient positioning system Market, by Application
- Surgery
- Disease Diagnosis
- Cancer Therapy
Global Patient positioning system Market, by End user
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Diagnostic Laboratories
- Other End Users
Patient positioning system Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Recent Developments
- In November 2022, C-RAD, a Swedish medical technology company, opens a precision radiation center in Faridabad, India.
- In July 2020, Hill-Rom Holdings Inc (US) launched surgical positioning innovations products named PST 500 Precision surgical table and Yellofins Apex Stirrups that provide caregivers with advanced OR technologies
- In September 2022, Getinge entered into a supply partnership with Medtronic, which recently received the CE mark for the Radiant-covered stent
- In September 2021, C-RAD and OPASCA entered collaboration. Radiation therapy departments have reached the next level of safety and accuracy with a solution combining C-RAD and OPASCA products, according to an agreement between C-RAD and OPASCA, a leader in innovative patient safety and workflow management solutions. C-RAD provides cutting-edge solutions ensuring exceptionally high precision, safety, and efficiency in advanced radiation therapy